Loading...

HT942524BMFRPIDA
DoD Bone Marrow Failure, Idea Development Award
Department of Defense
Dept. of the Army -- USAMRAA

General Information

Document Type:Grants Notice
Funding Opportunity Number:HT942524BMFRPIDA
Funding Opportunity Title:DoD Bone Marrow Failure, Idea Development Award
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative AgreementGrant
Category of Funding Activity:Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:5
Assistance Listings:12.420 -- Military Medical Research and Development
Cost Sharing or Matching Requirement:No
Version:Synopsis 1
Posted Date:Jun 07, 2024
Last Updated Date:Jun 07, 2024
Original Closing Date for Applications:Oct 09, 2024
Current Closing Date for Applications:Oct 09, 2024
Archive Date:Nov 08, 2024
Estimated Total Program Funding:$ 4,240,000
Award Ceiling:$
Award Floor:$

Eligibility

Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:

Additional Information

Agency Name:Dept. of the Army -- USAMRAA
Description:

The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. This award mechanism is designed to support new ideas. Proposed research studies should have a high probability of revealing new avenues of investigation. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Hypothesis-driven correlative studies associated with clinical trials that meet the innovative intent of this award mechanism are encouraged. An application that proposes a correlative study should be associated with a clinical trial(s), and the proposed study should facilitate the generation of new hypotheses or advance the understanding of disease biology, treatment mechanisms, or other innovative and impactful outcomes. Funding to conduct the clinical trial itself is outside the scope of this funding opportunity.


This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). ECIs will be assessed using different criteria for personnel during the review process (refer to Section II.E.1.a, Peer Review). Independent of career level, personnel on the proposed team should have a strong background in BMF disease research.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org